What Are the Preferences of Patients With Rheumatoid Arthritis for Treatment Modification? A Scoping Review

Suz Jack Chan, Hui Yee Yeo, Lisa K. Stamp, Gareth J. Treharne and Carlo A. Marra ()
Additional contact information
Suz Jack Chan: University of Otago
Hui Yee Yeo: University of Otago
Lisa K. Stamp: University of Otago
Gareth J. Treharne: University of Otago
Carlo A. Marra: University of Otago

The Patient: Patient-Centered Outcomes Research, 2021, vol. 14, issue 5, No 6, 505-532

Abstract: Abstract Objectives Optimal care of rheumatoid arthritis (RA) patients entails regular assessment of disease activity and appropriate adjustment of disease-modifying antirheumatic drugs (DMARDs) until a predefined treatment goal is achieved. This raises questions about the approach to treatment decision making among RA patients and their preference for associated treatment changes. We aimed to systematically identify and synthesize the available evidence of RA patients’ preferences regarding DMARD modification with an emphasis on escalating, tapering, stopping, or switching of DMARDs. Methods A scoping review was undertaken to gauge the breadth of evidence from the range of studies relating to RA patients’ preferences for DMARD modification. Pertinent databases were searched for relevant studies published between 1988 and 2019. Conventional content analysis was applied to generate themes about how patients perceive changes to their RA treatment. Results Of the 1730 distinct articles identified, 32 were included for review. Eight studies investigated RA patients’ perceptions of switching to other DMARDs, 18 studies reported RA patients’ preferences for escalating treatment, and six studies explored the possibility of tapering or stopping of biologic DMARDs. Four overarching themes relating to RA patients’ preferences for treatment modification were identified: (i) patient satisfaction, (ii) patients’ beliefs, (iii) information needs, and (iv) patient–clinician relationships. Conclusion Uptake of treatment changes in clinical practice can be improved by understanding how RA patients approach the decision to modify their treatment and how this relates to their satisfaction, beliefs, information needs, and relationships with clinicians. Future work is needed to systematically determine the significance of these factors in RA patients’ decision-making processes.

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40271-020-00488-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:patien:v:14:y:2021:i:5:d:10.1007_s40271-020-00488-7

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40271

DOI: 10.1007/s40271-020-00488-7

Access Statistics for this article

The Patient: Patient-Centered Outcomes Research is currently edited by Christopher I. Carswell

More articles in The Patient: Patient-Centered Outcomes Research from Springer, International Academy of Health Preference Research
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().